3rd International Protein Phosphorylation Drug Discovery World Summit
Venue: Marriott La Jolla
|Event Date/Time: Feb 28, 2005||End Date/Time: Mar 01, 2005|
Featured presentations this year include:
“Protein Kinases and Disease in the Postgenomic Era”
Tony Hunter, Ph.D.
Professor, Molecular and Cell Biology Laboratory
The Salk Institute
“Protein Kinase Inhibitors – Lessons Learned”
Doriano Fabbro, Ph.D.
Head in Signalling Pathways
Novartis Pharma AG
New for 2005!
This year’s program will spotlight an interactive panel discussion where leaders in field will discuss varies topics such as: meaningful selectivity, drugability of kinases, relevance of animal models to clinical experience, pitfalls for failures in kinase clinical programs and more. Panel participants include: Doriano Fabbro (Novartis Pharma AG), Tony Hunter (The Salk Institute), Blaine Knight (GlaxoSmithKline), Steven Pelech (Kinexus Bioinformatics) and discussion leader, Peter Blume-Jensen (Serono Reproductive Biology Institute).
In two days, you’ll be quickly updated on the state-of-the-art of protein kinase and phosphatase-based therapeutics, and come away with an overall perspective that shall enable you to apply what you learn to your own in-house efforts, select new avenues for investigation, or prospect new partners for licensing and other collaborations.
We look forward to welcoming you in San Diego!